-
-
Overview
-
Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview
Everolimus
Everolimus
Catalog Number:
I002097659UBP
Mfr. No.:
F6140
Price:
$220
Size:
5 mg
Quantity:
Add to Cart: